[English] 日本語
Yorodumi Papers
- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods
Author
Journal
IF

-
Structure paper

TitleStructural Pharmacology of Bufotenine Derivatives in Activating the 5-HT Receptor for Therapeutic Potential in Depression and Anxiety.
Journal, issue, pagesResearch (Wash D C), Vol. 8, Page 0987, Year 2025
Publish dateDec 23, 2025
AuthorsShu-Jie Li / Qing-Ning Yuan / Wen-Yuan Wu / Zhi-Han Chen / Duo Chen / Hong Shan / Qin-Yu Chu / Wen Hu / Kai Wu / Tao Liu / Yu-Yu Zhu / Li Hou / Jing Zhou / Jia Duan / Jin-Ao Duan / H Eric Xu / Hong-Yue Ma /
PubMed AbstractThe 5-HT receptor is a critical target in the treatment of depression and anxiety. Bufotenine derivatives, such as 5-methoxy-,-dimethyltryptamine (5-MeO-DMT), 5-hydroxy-,-dimethyltryptamine (5-OH-DMT) ...The 5-HT receptor is a critical target in the treatment of depression and anxiety. Bufotenine derivatives, such as 5-methoxy-,-dimethyltryptamine (5-MeO-DMT), 5-hydroxy-,-dimethyltryptamine (5-OH-DMT), and 5-hydroxy-,,-dimethyltryptamine-derived from traditional Chinese medicine-have shown antidepressant potential. However, the structural basis of their interaction with 5-HT and their pharmacological profiles remain incompletely understood. This study investigated bufotenine derivatives acting on multiple serotonin receptors, highlighting 5-HT as a key mediator of antidepressant effects while recognizing 5-HT as primarily responsible for hallucinogenic outcomes, to identify candidates with therapeutic efficacy but reduced hallucinogenic liability. We determined the cryo-electron microscopy structures of 5-HT bound to selected bufotenine derivatives. Functional assays in mice, including behavioral tests and receptor activation studies, were used to evaluate the antidepressant of each compound. Structural analysis revealed that all bufotenine derivatives engage conserved motifs within the 5-HT binding pocket, with 5-OH-DMT displaying a distinct interaction pattern. Behavioral assays showed that 5-OH-DMT and 5-MeO-DMT retained strong antidepressant and anxiolytic effects. These pharmacological differences correlate with their unique receptor binding conformation. This study delineated the structural pharmacology of bufotenine derivatives at the 5-HT receptor, identifying 5-OH-DMT and 5-MeO-DMT as promising antidepressant and anxiolytic candidates. The findings establish a molecular framework for the development of next-generation nonhallucinogenic therapeutics aimed at 5-HT.
External linksResearch (Wash D C) / PubMed:41446874 / PubMed Central
MethodsEM (single particle)
Resolution2.54 - 2.63 Å
Structure data

EMDB-62593, PDB-9kvg:
A Cryo_EM structure of 5_HT1A complex with 5-Meo-DMT
Method: EM (single particle) / Resolution: 2.63 Å

EMDB-62594, PDB-9kvh:
A Cryo_EM structure of 5_HT1A complex with TMT
Method: EM (single particle) / Resolution: 2.59 Å

EMDB-62595, PDB-9kvi:
A Cryo_EM structure of 5_HT1A complex with DMT
Method: EM (single particle) / Resolution: 2.54 Å

Chemicals


ChemComp, No image

ChemComp-YFW:
Unknown entry

ChemComp-CHO:
GLYCOCHENODEOXYCHOLIC ACID / detergent*YM

ChemComp-Y01:
CHOLESTEROL HEMISUCCINATE

ChemComp-J40:
[(2R)-1-[oxidanyl-[(2R,3R,5S,6R)-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-3-tetradecanoyloxy-propan-2-yl] (5E,8E)-hexadeca-5,8,11,14-tetraenoate

ChemComp-HOH:
WATER

PDB-1eg9:
NAPHTHALENE 1,2-DIOXYGENASE WITH INDOLE BOUND IN THE ACTIVE SITE.

ChemComp-CLR:
CHOLESTEROL

PDB-1eg8:
Unknown entry

Source
  • homo sapiens (human)
KeywordsMEMBRANE PROTEIN / GPCR / 5_HT1A

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

  • Database of articles cited by EMDB, PDB, and SASBDB entries
  • Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi

Read more